$HNGE

Insight Holdings Group, LLC sold $10.2M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 142,311 indirectly-held shares of Hinge Health, Inc. (HNGE) at $71.67 ($10.20M total) across 2 trades on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 25, 2026, 1:57 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Bearish
medium confidence
Mentioned
$HNGE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishLow
01

Why it matters

A 10% owner sold ~$10.2M of HNGE shares via open-market trades under a Rule 10b5-1 plan, leaving 0 shares after the transaction.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure reduces the immediacy of any negative fundamental inference.

03

What to watch

The filing does not reveal whether other insiders or the company have offsetting buys; also, indirect holdings may not map cleanly to near-term control or operating outlook.

Relevance 6/10Novelty 6/10Timing: filed after-hours on 2026-06-24; relevant for next session positioning

Background

The article is an SEC Form 4 insider transaction disclosure for Hinge Health, Inc. (HNGE).

Company-level read

Ticker impact

$HNGEBearishMedium confidence
Context

SEC Form 4 shows Insight Holdings Group, LLC (10% owner) sold 142,311 HNGE shares in open-market trades at ~$71.67.

Expected impact

Near-term sentiment risk; likely limited fundamental impact unless follow-on selling continues.

Evidence & confidence

The filing is primary-source and sizable (~$10.2M), but it is a pre-arranged 10b5-1 plan, which typically lowers the signal strength versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio rebalancing rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider sale; 142,311 shares sold at ~$71.6669.

  • Insight Holdings Group, LLC

    10% owner who executed the open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.